2. Risk of bias of included trialsa.
Trial | Generation of allocation sequence | Allocation concealment | Blinding | Inclusion of all randomized participants in the final analysisb |
Bounyasong 2001 | Unclear | Unclear | None | Adequate |
Coulibaly 2006 | Adequate | Unclear | None | Inadequate |
Kalilani 2007 | Adequate | Adequate | Outcome assessor | Inadequate |
Mbanzulu 1993 | Inadequate | Unclear | Outcome assessor | Adequate |
McGready 2000 | Adequate | Unclear | None | Adequate |
McGready 2001a | Unclear | Unclear | None | Inadequate |
McGready 2005 | Adequate | Adequate | Outcome assessor | Adequate |
Nosten 1993b | Inadequate | Unclear | None | Inadequate |
Sowunmi 1998a | Unclear | Unclear | None | Adequate |
Tagbor 2006 | Adequate | Adequate | Participant, treatment provider, outcome assessor, data analyst | Adequate |
aSee 'Assessment of risk of bias in included studies' for the assessment methods, and the 'Characteristics of included studies' for the methods used in each trial. bFor primary outcomes.